Increasing the Tumor-to-Blood Ratio by Click-Cleavable Radioimmunoimaging with [89Zr]Zr-DFO-Trans-Cyclooctene-Trastuzumab in Mice

被引:0
|
作者
de Roode, K. E. [1 ,2 ]
Vlastara, M. [1 ]
Rossin, R. [1 ]
Hoeben, F. J. M. [3 ]
Boswinkel, M. [2 ]
Kleijn, L. H. J. [1 ]
Nagarajah, J. [2 ]
Heskamp, S. [2 ]
Rijpkema, M. [2 ]
Robillard, M. S. [1 ]
机构
[1] Tagworks Pharmaceut, Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Dept Med Imaging, Med Ctr, Nijmegen, Netherlands
[3] SyMO Chem, Eindhoven, Netherlands
关键词
RELEASE;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OP-220
引用
收藏
页码:S98 / S98
页数:1
相关论文
共 4 条
  • [1] Click-to-Release: Cleavable Radioimmunoimaging with [89Zr]Zr-DFO-Trans-Cyclooctene-Trastuzumab Increases Tumor-to-Blood Ratio
    Vlastara, Maria
    Rossin, Raffaella
    Hoeben, Freek J. M.
    de Roode, Kim E.
    Boswinkel, Milou
    Kleijn, Laurens H. J.
    Nagarajah, James
    Rijpkema, Mark
    Robillard, Marc S.
    THERANOSTICS, 2023, 13 (12): : 4004 - 4015
  • [2] Comparative distribution of white blood cells and stem cells radiolabeled with [89Zr]Zr-DFO-Bn-NCS, [89Zr]Zr-Hy3ADA5-NCS and [89Zr]Zr-Hy3ADA5-SA in normal athymic nude mice
    Bansal, Aditya
    Klasen, Benedikt
    Sharma, Shalini
    Rosch, Frank
    Pandey, Mukesh
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63
  • [3] Tumor uptake and tumor/blood ratios for [89Zr]Zr-DFO-trastuzumab-DM1 on microPET/CT images in NOD/SCID mice with human breast cancer xenografts are directly correlated with HER2 expression and response to trastuzumab-DM1
    Al-saden, Noor
    Cai, Zhongli
    Reilly, Raymond M.
    NUCLEAR MEDICINE AND BIOLOGY, 2018, 67 : 43 - 51
  • [4] A comparison of DFO and DFO* conjugated to trastuzumab-DM1 for complexing 89Zr - In vitro stability and in vivo microPET/CT imaging studies in NOD/SCID mice with HER2-positive SK-OV-3 human ovarian cancer xenografts
    Cho, Hyungjun
    Al-Saden, Noor
    Lam, Heather
    MObus, Juri
    Reilly, Raymond M.
    Winnik, Mitchell A.
    NUCLEAR MEDICINE AND BIOLOGY, 2020, 84-85 : 11 - 19